Jim Simons's position in Gilead Sciences is currently worth $728 Million. That's 0.97% of their equity portfolio (5th largest holding). The first Gilead Sciences trade was made in Q2 2013. Since then Jim Simons bought shares nineteen more times and sold shares on eighteen occasions. The stake costed the investor $675 Million, netting the investor a gain of 7.9% so far.
In this article we take a look at Jim Simons Stock Portfolio: 10 Biggest Healthcare Stocks. Click to skip ahead and see Jim Simons Stock Portfolio: 5 Biggest...Yahoo Finance, 3 months ago
Jim Simons is the founder and hedge fund manager of Renaissance Technologies, which currently has a total portfolio value north of $77 billion, per Stock Cir...Benzinga, 4 months ago